CTOs on the Move


 
XIFIN, Inc. is an innovative software and services company dedicated to optimizing the economics of healthcare. The company`s cloud-based technology and business intelligence platform links healthcare stakeholders in the delivery and reimbursement of care, optimizing both business and patient outcomes and providing informed, streamlined diagnostic and business decision-making.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.xifin.com
  • 12225 El Camino Real
    San Diego, CA USA 92130
  • Phone: 858.793.5700

Executives

Name Title Contact Details
John Kelly
Chief Information Officer Profile

Similar Companies

Jet Health Incorporated

It`s good to be home! Jet Health is a provider of skilled home health, hospice, personal care, and companion services. Founded in April 2016, Jet Health is building a national platform through organic growth, strategic acquisitions, and de novo build-outs in target markets. These markets are typically mid-sized cities that have under served and growing Medicare populations. Jet Health leverages local brands and operating expertise while sharing best practices across its companies and centralizes traditional back office functions. The company believes that its four cornerstones: superior service, clinical excellence, compliant business practices and an employee centric environment, provide a solid foundation upon which to build a successful company in the home health marketplace.

PrimeMyBody

PrimeMyBody is a global company that helps people to live wellness and create lifestyle. We formulate life-changing products with quality in mind, and that means using nothing but the best nature has to offer. Being healthy isn`t a fad or a trend... instead, it`s a lifestyle, and our goal is to show the world just that.

Ccs

Ccs is a Woburn, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

IMAC Regeneration Centers

IMAC Regeneration Centers offers long-term solutions for chronic musculoskeletal conditions without surgery or opioids. This state-of-the-art medical treatment utilizes a combination of regenerative medicine and rehabilitation to prevent the most common unnecessary surgeries, including spinal fusion and laminectomy, and knee and hip replacements. Each of these surgeries require an opioid prescription 99.9% of the time, leading to a high risk of addiction and never returning to work.

Halberd Corporation

Halberd Corporation has acquired exclusive licenses to two issued patents and four provisional patent applications related to the extracorporeal treatment of blood-borne diseases and Cerebrospinal Fluid related diseases, with particular focus on the treatment and rapid detection of Covid-19 and other virus`. The issued patents` extracorporeal technology is applicable to a significant number of the most debilitating and often fatal illnesses affecting mankind: PTSD, CTE (Chronic Traumatic Encephalopathy) and Cancer, among others. We have developed an aggressive timetable to advance the development of these breakthrough technologies through laboratory, hospital, and clinical trials. In addition, we have initiated the development of potential patient trial application lists. Our management team has extensive experience and contacts in the medical/pharmaceutical fields as well as a demonstrated track record of launching new business ventures in a competitive environment.